A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
Clinical trial NCT05983367 · TERMINATED
Trial details
- NCT number
- NCT05983367
- Sponsor
- Inspirna, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-10
- Primary completion
- 2025-01-31
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.